Influence of coping styles on quality of life in men with new and increasing lower urinary tract symptoms: The Krimpen study in community-dwelling men

Urologia Internationalis

Volumn 79, Issue 3, 2007, Pages 226-230

  Kok, Esther T ^a   Groeneveld, Frans P M J ^a   Busschbach, Jan J V ^a   Hop, Wim C J ^a   Bosch, J L H Ruud ^b   Thomas, Siep ^a   Bohnen, Arthur M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coping style; Longitudinal and IPSS; Lower urinary tract symptoms; Quality of life

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DATA ANALYSIS; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LONGITUDINAL STUDY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SICKNESS IMPACT PROFILE; STATISTICAL SIGNIFICANCE; UTRECHT COPING LIST;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGED; ATTITUDE TO HEALTH; COST OF ILLNESS; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; UROLOGIC DISEASES;

EID: 35348856320     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107954     Document Type: Article

References (15)

1. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ: EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547-554.
2. Roesch SC, Weiner B: A meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res 2001;50:205-219.
3. Lewandowski W: Psychological factors in chronic pain: a worthwhile undertaking for nursing? Arch Psychiatr Nurs 2004;18:97-105.
4. Ritsner M, Ben-Avi I, Ponizovsky A, Timinsky I, Bistrov E, Modai I: Quality of life and coping with schizophrenia symptoms. Qual Life Res 2003;12:1-9.
5. Riise T, Lund A: Prognostic factors in major depression: a long-term follow-up study of 323 patients. J Affect Disord 2001;65:297-306.
6. Cronqvist A, Klang B, Bjorvell H: The use and efficacy of coping strategies and coping styles in a Swedish sample. Qual Life Res 1997;6:87-96.
7. Smout S, Koudstaal PJ, Ribbers GM, Janssen WG, Passchier J: Struck by stroke: a pilot study exploring quality of life and coping patterns in younger patients and spouses. Int J Rehabil Res 2001;24:261-268.
8. Schreurs PJG, van de Willige G, Brosschot JF, Tellegen B, Graus GMH: Utrecht Coping-list: UCL/De Utrechtse Copinglijst: UCL. Lisse, Swetz & Zeitlinger, 1993.
9. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL: Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen Study of male urogenital tract problems and general health status. BJU Int 2000;85:665-671.
10. Joosten J, Drop MJ: De betrouwbaarheid en vergelijkbaarheid van de drie versies van de VOEG (The reliability and comparability of the three versions of the ISH). Gezondheid Samenleving 1987;8:251-265.
11. Jacobs HM, Luttik A, Touw-Otten FW, de Melker RA: De 'sickness impact profile'; resultaten van een valideringsonderzoek van de Nederlandse versie (The sickness impact profile; results of an evaluation study of the Dutch version). Ned Tijdschr Geneeskd 1990;134:1950-1954.
12. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al: The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992;148:1549-1557.
13. Kok ET, Bohnen AM, Groeneveld FP, Busschbach JJ, Blanker MH, Bosch JL: Changes in disease specific and generic quality of life related to changes in lower urinary tract symptoms: the Krimpen Study. J Urol 2005;174:1055-1058.
14. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK: Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care 1995;33(suppl):AS145-AS155.
15. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-2398.